Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

Zachary Hamilton; Hak J. Lee; Juan Jimenez; Brian R. Lane; Song Wang; Alp T. Beksac; Kyle Gillis; Amy Alagh; Conrad Tobert; James M. Randall; Christopher J. Kane; Frederick Millard; Steven C. Campbell; Ithaar H. Derweesh

doi:10.1111/bju.13490

Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

BJU International ◽

10.1111/bju.13490 ◽

2016 ◽

Vol 118 (6) ◽

pp. 927-934 ◽

Cited By ~ 4

Author(s):

Zachary Hamilton ◽

Hak J. Lee ◽

Juan Jimenez ◽

Brian R. Lane ◽

Song Wang ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Platelet Count ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Prognostic Indicator ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

MP57-14 CHANGE IN PLATELET COUNT AS A PROGNOSTIC INDICATOR FOR RESPONSE TO NEOADJUVANT TYROSINE KINASE INHIBITOR THERAPY IN METASTATIC RENAL CELL CARCINOMA

The Journal of Urology ◽

10.1016/j.juro.2014.02.1789 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Hak Lee ◽

Nishant Patel ◽

Ryan Kopp ◽

Michael Liss ◽

Reza Mehrazin ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Platelet Count ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Prognostic Indicator ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy

International Journal of Clinical Oncology ◽

10.1007/s10147-016-1032-7 ◽

2016 ◽

Vol 22 (1) ◽

pp. 126-135 ◽

Cited By ~ 5

Author(s):

Hiroki Ishihara ◽

Takafumi Yagisawa ◽

Tsunenori Kondo ◽

Kenji Omae ◽

Toshio Takagi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Tumor Shrinkage ◽

First Line ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

Cancer ◽

10.1002/cncr.28634 ◽

2014 ◽

Vol 120 (11) ◽

pp. 1647-1655 ◽

Cited By ~ 24

Author(s):

Jorge A. Garcia ◽

Gary R. Hudes ◽

Toni K. Choueiri ◽

Walter M. Stadler ◽

Laura S. Wood ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Disease Progression ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Phase 2 ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study

International Journal of Urology ◽

10.1111/iju.14466 ◽

2020 ◽

Author(s):

Shingo Hatakeyama ◽

Sei Naito ◽

Kazuyuki Numakura ◽

Renpei Kato ◽

Tomoyuki Koguchi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Retrospective Study ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Cytoreductive Nephrectomy ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

A Case of Metastatic Renal Cell Carcinoma to the Maxillary Sinus Treated with Tyrosine Kinase Inhibitor

Korean Journal of Otorhinolaryngology - Head and Neck Surgery ◽

10.3342/kjorl-hns.2012.55.11.717 ◽

2012 ◽

Vol 55 (11) ◽

pp. 717 ◽

Cited By ~ 2

Author(s):

Young Hyo Kim ◽

Jae Eun Kim ◽

Sungmin Park ◽

Tae Young Jang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Maxillary Sinus ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor

Download Full-text

Faculty Opinions recommendation of Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717979900.793471988 ◽

2013 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

Cytoreductive Nephrectomy

Download Full-text

Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2942-1 ◽

2015 ◽

Vol 77 (2) ◽

pp. 339-347 ◽

Cited By ~ 3

Author(s):

Dong-Hoe Koo ◽

Inkeun Park ◽

Jin-Hee Ahn ◽

Dae-Ho Lee ◽

Dalsan You ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Long Term Outcomes ◽

Tyrosine Kinase Inhibitor Discontinuation

Download Full-text

Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis

European Urology ◽

10.1016/j.eururo.2017.07.019 ◽

2017 ◽

Vol 72 (6) ◽

pp. 1027-1028 ◽

Cited By ~ 1

Author(s):

Giandomenico Roviello ◽

Daniele Generali

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Meta Analysis

Download Full-text

Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyx161 ◽

2017 ◽

Vol 47 (12) ◽

pp. 1175-1181 ◽

Cited By ~ 6

Author(s):

Hiroki Ishihara ◽

Tsunenori Kondo ◽

Hironori Fukuda ◽

Kazuhiko Yoshida ◽

Kenji Omae ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Renal Function ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

First Line ◽

Tyrosine Kinase Inhibitor Therapy ◽

Function Change

Download Full-text

The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

Neoplasia ◽

10.1016/j.neo.2019.07.004 ◽

2019 ◽

Vol 21 (9) ◽

pp. 921-931 ◽

Cited By ~ 1

Author(s):

Guangxi Sun ◽

Xingming Zhang ◽

Zhenhua Liu ◽

Sha Zhu ◽

Pengfei Shen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tumor Progression ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Inhibitor Resistance

Download Full-text